CYP17A1 and breast cancer: Several studies have reported conflicting results of menopausal and CYP17 polymorphism: the study by Dunning et al. [17] showed the association between increased A2 genotype and premenopausal breast cancer; while Feigelson et al. [18] reported increasing frequency of A2 genotype associated with postmenopausal BC patients.